Clarinex-D 12 Hour

Active Ingredient(s): Desloratadine + Pseudoephedrine Sulfate
FDA Approved: * February 1, 2006
Pharm Company: * SCHERING
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Clarinex-D 12 Hour Overview

Desloratadine (trade names Clarinex and Aerius) is a tricyclic H1 antagonist that is used to treat allergies. It is an active metabolite of loratadine. It was patented in 1984 and came into medical use in 2001.[3] Contents 1 Medical uses 2 Side effects 3 Interactions 4 Pharmacology 4.1 Pharmacodynamics 4.2 Pharmacokinetics 4.3 Pharmacogenomics 5 Society and culture 5.1 Economics 6 See also 7 References 8 External links Medical uses Desloratadine is used to treat ...

Read more Clarinex-D 12 Hour Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Desloratadine

Recent Clarinex-D 12 Hour Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Desloratadine + Pseudoephedrine Sulfate
  • Tablet, Extended Release: 2.5mg + 120mg, 5mg + 240mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Clarinex-D 12 Hour: (2 results)

Sorted by National Drug Code
  • 0085-1322 Clarinex-d (Desloratadine 2.5 mg / Pseudoephedrine Sulfate 120 mg) 12 Hr Extended Release Tablet by Merck Sharp & Dohme Corp.
  • 54868-5708 Clarinex-d (Desloratadine 2.5 mg / Pseudoephedrine Sulfate 120 mg) 12 Hr Extended Release Tablet by Physicians Total Care, Inc.

Drugs with one or more similar ingredients: (8 results)